High-level immunogenicity is achieved with adjuvanted pandemic H1N12009 vaccine and improved with booster dosing in a randomized trial of HIV-infected adults
HIV Clin Trials , 2012; 13:23–32. doi: 10.1310/hct1301-23
HIV Clin Trials , 2012; 13:23–32. doi: 10.1310/hct1301-23